Navigation Links
LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers, Upcoming Webinar Hosted by Xtalks
Date:6/23/2020

The field of quantitation of large molecules or proteins has been around for a long time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of mass spectrometry in this field has gained a lot of momentum in the last several years.

This now necessitates the question “How do you choose which approach to use (LBA or MS)?” In many cases, either technology can answer the question, but there are definitely times when one technology has advantages over the other. There are several questions which might lead to specific direction, such as “what type of reagents are available?” or “do you need to differentiate a small amino acid change?”

This webinar will give an overview of each approach and discuss the types of questions that will help guide one to choose the correct technology. For the LBA, we will discuss the different types of ligand binding assays, answers to common questions that can lead to performing LBA vs. hybrid LCMS and some advantages of LBA over LCMS methodologies.

For Hybrid LCMS, we will discuss and highlight various approaches for using immunoaffinity LCMS or hybrid LCMS, from enrichment at the protein level to enrichment at the peptide level, using either bead-based or column-based enrichment strategies.

The presenters will also give examples and case studies of where each technology was applied successfully and where they had to pivot to an alternate technology.

Join Franklin Spriggs, MS Director, Biopharmaceutical LBA Services, KCAS Bioanalytical and Biomarker Services and Dawn Dufield, PhD, Director, Biopharmaceutical LC-MS/MS Services, KCAS Bioanalytical and Biomarker Services in a live webinar on Friday, July 10, 2020 at 12pm EDT (5pm BST/UK).

For more information or to register for this event, visit LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/lba_and_hybrid_lcms_quantitation_of_biotherapeutics_and_biomarkers_upcoming_webinar_hosted_by_xtalks/prweb17205839.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Boekel Scientific rapidFISH Hybridization Oven Used to Study the Effects of Humidity on a DNA Labeling System
2. Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020
3. How are hybridized species affecting wildlife?
4. Statistical model predicts performance of hybrid rice
5. LSTM Researchers demonstrate adaptive potential of hybridization in mosquito species
6. Study finds climate change accelerates hybridization between native, invasive trout
7. Hybrid technology could make Star Trek-style tricorder a reality
8. Hybrid vehicles more fuel efficient in India, China than in US
9. Solar-induced hybrid fuel cell produces electricity directly from biomass
10. Study discovers natural hybridization produced dolphin species
11. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/2/2020)... ... 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , a ... for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology Association ... of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 single ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... (PRWEB) , ... August 13, 2020 , ... True ... the creation of its Scientific Advisory Board (SAB) to research the medical potential of ... can be enhanced when combined with terpenes. The board is focused on expanding the ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed that ... FDA compliance consulting has been named on its annual Inc. 5000 list, the ... unique look at the most successful companies within the American economy’s most dynamic ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell ... into a strategic partnership whereby Catalent will provide support for the development, manufacturing, ...
Breaking Biology Technology: